SCHEMBL30481263

SCHEMBL30481263

Cn1ccc(C(=O)Nc2ncc(-c3ccc(C#N)c4[nH]ccc34)s2)cc1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 3/20 0.41
▸ CSNK2A1 P68400 3/20 0.41
▸ BRD4 O60885 5/20 0.40
▸ PDE10A Q9Y233 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TAF1 P21675 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ RAB9A P51151 1/20 0.35
▸ CECR2 Q9BXF3 1/20 0.35
▸ KDR P35968 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ POLQ O75417 1/20 0.33
▸ STIM1 Q13586 1/20 0.33
▸ ORAI1 Q96D31 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25420455 1.00 CSNK2A2 (0.41) CSNK2A2CSNK2A1BRD4PDE10AKDM4E
SCHEMBL25612824 0.81 MAPT (0.42) CSNK2A2CSNK2A1PDE10AKDM4EMEN1
SCHEMBL25612327 0.77 MKNK1 (0.54) —
SCHEMBL25605965 0.75 XDH (0.42) CSNK2A2CSNK2A1PDE10AKDR
SCHEMBL25613674 0.66 PDE10A (0.43) CSNK2A2CSNK2A1PDE10AKDM4EMEN1
SCHEMBL25605163 0.66 PDE10A (0.49) CSNK2A2CSNK2A1PDE10AKDM4EMEN1
SCHEMBL25421541 0.66 XDH (0.41) CSNK2A2CSNK2A1PDE10AKDR
SCHEMBL25610594 0.65 MKNK1 (0.55) RAB9A
SCHEMBL25418143 0.63 XDH (0.42) CSNK2A2CSNK2A1PDE10AKDRSTIM1
SCHEMBL31501375 0.63 CSNK2A2 (0.50) CSNK2A2CSNK2A1PDE10AKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118843626-A Heterocyclic compounds as DYRK1A inhibitors 普罗塞纳生物科学有限公司 2024-10-25 — — CN disclosed
EP-4444421-A2 HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS Prothena Biosciences Limited (IE) 2024-10-16 — — EP disclosed
WO-2023107714-A2 METHODS FOR TREATING NEUROLOGICAL DISORDERS PROTHENA BIOSCIENCES LIMITED (IE) 2023-06-15 — — WO disclosed
Send feedback